These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27626908)

  • 21. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.
    Phatak SS; Gatica EA; Cavasotto CN
    J Chem Inf Model; 2010 Dec; 50(12):2119-28. PubMed ID: 21080692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
    Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding.
    Potterton A; Heifetz A; Townsend-Nicholson A
    Methods Mol Biol; 2018; 1705():335-343. PubMed ID: 29188570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional descriptors for aminergic GPCRs: dependence on docking conformation and crystal structure.
    Jastrzębski S; Sieradzki I; Leśniak D; Tabor J; Bojarski AJ; Podlewska S
    Mol Divers; 2019 Aug; 23(3):603-613. PubMed ID: 30484023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life beyond the Tanimoto coefficient: similarity measures for interaction fingerprints.
    Rácz A; Bajusz D; Héberger K
    J Cheminform; 2018 Oct; 10(1):48. PubMed ID: 30288626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.
    Miszta P; Jakowiecki J; Rutkowska E; Turant M; Latek D; Filipek S
    Methods Mol Biol; 2018; 1705():265-296. PubMed ID: 29188567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM; Brown AJ; Marshall FH; Mason JS
    Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
    Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
    J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PyPLIF HIPPOS-Assisted Prediction of Molecular Determinants of Ligand Binding to Receptors.
    Istyastono EP; Yuniarti N; Prasasty VD; Mungkasi S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.
    Coudrat T; Christopoulos A; Sexton PM; Wootten D
    PLoS One; 2017; 12(4):e0174719. PubMed ID: 28380046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural protein-ligand interaction fingerprints (SPLIF) for structure-based virtual screening: method and benchmark study.
    Da C; Kireev D
    J Chem Inf Model; 2014 Sep; 54(9):2555-61. PubMed ID: 25116840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual fragment screening on GPCRs: a case study on dopamine D3 and histamine H4 receptors.
    Vass M; Schmidt É; Horti F; Keserű GM
    Eur J Med Chem; 2014 Apr; 77():38-46. PubMed ID: 24607587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.
    Szwabowski GL; Griffing M; Mugabe EJ; O'Malley D; Baker LN; Baker DL; Parrill AL
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.